NCT00467311View on ClinicalTrials.gov

Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

April 30, 2008

Conditions
Contrast Induced NephropathyAcute Renal Failure
Trial Locations (1)

01480

Ignacio Chávez National Institute of Cardiology, Mexico City

All Listed Sponsors
lead

National Heart Institute, Mexico

OTHER_GOV

NCT00467311 - Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients | Biotech Hunter | Biotech Hunter